Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01007760 · ClinicalTrials.gov registry record · NA
Dose-dependent Effects of Second-hand Smoke on Vascular Function
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01007760: Completed NA study, sponsored by University of California, San Francisco.
NCT01007760 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 33 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01007760, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.
Interventions
- OTHER Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01007760 record still lists
NCT01007760 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 33 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke is the first listed.
NCT01007760 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01007760 about?
NCT01007760 is a clinical study titled "Dose-dependent Effects of Second-hand Smoke on Vascular Function". The purpose of this study is to determine the vascular effects of brief second-hand smoke exposure on normal healthy individuals.
What is the current status of trial NCT01007760?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2009-11. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01007760?
The interventions under investigation include: Respirable suspended particles (RSP) PM 2.5 dose of second-hand smoke (OTHER).
Who is sponsoring clinical trial NCT01007760?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01007760's enrollment target sits among peer trials
33 1574th of 2000 higher than 423 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02861898 · 33 participants · Phase 1
Super-selective Intra-arterial Repeated Infusion of Cetuximab for the Treatment of Newly Diagnosed Glioblastoma
- NCT04871607 · 33 participants · Phase 2
Yttrium-90 Labeled Anti-CD25 Monoclonal Antibody Combined With BEAM Chemotherapy Conditioning for the Treatment of Primary Refractory or Relapsed Hodgkin Lymphoma
- NCT05071937 · 33 participants · Phase 2
ZEN003694 Combined With Talazoparib in Patients With Recurrent Ovarian Cancer
- NCT05168618 · 33 participants · Phase 2
Cabozantinib and Atezolizumab for the Treatment of Metastatic Castration-Resistant Prostate Cancer, The AtezoCab Trial
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia